Finding the Patients We’re Missing Rare diseases often remain undiagnosed for years, leaving patients without timely treatment and care. Despite
Introduction Volv Global participation in Faces of Industrial Research 2026 reflects its commitment to connecting scientific innovation with real-world healthcare
In 2024, Sanofi – working in partnership with The BMJ – released the Rairity: Air Time For Rare Diseases podcast
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Introduction: COPD as a “Syndrome,” Not Just One Disease Chronic
“The patient voice” is shorthand for patients’ and caregivers’ lived experience—captured in a way that can inform decisions. In other
Photos from Digital Lounge @Davos. Volv Global CEO and founder Christopher Rudolf has been
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Introduction: A Silent Disease Becoming a Public Health Emergency Metabolic
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Knowing When To Treat – AI for Transformation, Infection Risk, and
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Early detection and personalised treatment in chronic lymphocytic leukaemia (CLL) remain
Artificial intelligence continues to redefine clinical development yet much of the conversation remains driven by hype rather than hard evidence.
Volv Global continues to shape the future of AI in healthcare. This November, at Frontiers Health 2025 in Berlin, CEO
By Léon Van Wouwe, Clinical Innovation Director, Volv Global A Hidden Cancer in Plain Sight Multiple myeloma (MM) has
